Detection and Prediction of Breast Cancer Using Double Phase Tc-99m MIBI Scintimammography in Comparison with MRI

Onkologie

Volumn 32, Issue 10, 2009, Pages 556-560

  Kim, In Joo ^a   Kim, Yong Ki ^a   Kim, Seong Jang ^a  

^a Pusan National University Hospital   (South Korea)

Author keywords

Breast cancer; Contrast enhanced MRI; Scintimammography; Tc 99m MIBI

Indexed keywords

GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; ARTICLE; BREAST ABSCESS; BREAST CANCER; BREAST DISEASE; BREAST FIBROADENOMA; CANCER DIAGNOSIS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FIBROCYSTIC BREAST DISEASE; HUMAN; INTERMETHOD COMPARISON; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MUCINOUS CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; SCINTIMAMMOGRAPHY; SENSITIVITY AND SPECIFICITY;

BREAST NEOPLASMS; FEMALE; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI;

EID: 70350752309     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000232316     Document Type: Article

References (21)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ: Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
2. Nyström L, Andersson I, Bjurstam N, Frisell J, Nordenskjöld B, Rutqvist LE: Long-term effects of mammography screening: Updated overview of the Swedish randomized trials. Lancet 2002;359:909-919.
3. Orel SG, Kay N, Reynolds C, Sullivan DC: BIRADS categorization as a predictor of malignancy. Radiology 1999;211:845-850.
4. Alonso O, Massardo T, Delgado LB, Horvath J, Kabasakal L, Llamas-Olier A, Maunda KK, Morales R, Padhy AK, Shankar UR: Is 99mTcsestamibi scintimammography complementary to conventional mammography for detecting breast cancer in patients with palpable masses ? J Nucl Med 2001;42:1614-1621.
5. Prats E, Razola P, Sainz JM, Tardín L, Andrés A, Abós MD, García F, Fernández J, Villavieja L, Banzo J: Scintimammography with 99mTc-MIBI in the clinical practice: Repercussion on the clinical management of the patient. Rev Esp Med Nucl 2007; 26:153-159.
6. Filippi L, Pulcini A, Remediani S, Masci E, Redler A, Scopinaro F, De Vincentis G: Usefulness of scintimammography with Tc-99m MIBI in clinical practice. Clin Nucl Med 2006;31:761-763.
7. Kim SJ, Kim IJ, Kim YK, Bae YT: Tc-99m MIBI scintimammography in suspected breast cancer patients: Unicenter trial (abstract). J Nucl Med 2000;41(suppl):144P.
8. Fischer U, Kopka L, Brinck U, Korabiowska M, Schauer A, Grabbe E: Prognostic value of contrast- enhanced MR mammography in patients with breast cancer. Eur Radiol 1997;7:1002-1005.
9. Kuhl CK, Mielcareck P, Klaschik S, Leutner C, Wardelmann E, Gieseke J, Schild HH: Dynamic breast MR imaging: Are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 1999;211:101-110.
10. Orel SG: High-resolution MR imaging for the detection, diagnosis, and staging of breast cancer. Radiographics 1998;18:903-912.
11. Kuhl CK: MRI of breast tumors. Eur Radiol 2000;10: 46-58.
12. Kim SJ, Kim IJ, Bae YT, Kim YK, Kim DS: Incremental diagnostic value of quantitative analysis of double phase Tc-99m MIBI scintimammography for the detection of primary breast cancer additive to visual analysis. Breast Cancer Res Treat 2004;83: 129-138.
13. Heywang SH, Wolf A, Pruss E, Hilbertz TH, Eiermann W, Permanetter W: MR imaging of the breast with Gd-DTPA: Use and limitations. Radiology 1989;171:95-103.
14. Gilles R, Guinebretière JM, Lucidarme O, Cluzel P, Janaud G, Finet JF, Tardivon A, Masselot J, Vanel D: Nonpalpable breast tumors: diagnosis with contrast-enhanced subtraction dynamic MR imaging. Radiology 1994;191:625-631.
15. Fobben ES, Rubin CZ, Kalisher L, Dembner AG, Seltzer MH, Santoro EJ: Breast MR imaging with commercially available techniques: Radiologic-pathologic correlation. Radiology 1995;196:143-152.
16. Palmedo H, Grünwald F, Bender H, Schomburg A, Mallmann P, Krebs D, Biersack HJ: Scintimammography with technetium-99m methoxyisobutylisonitrile: comparison with mammography and magnetic resonance imaging. Eur J Nucl Med Mol Imaging 1996;23:940-946.
17. Imbriaco M, Del Vecchio S, Riccardi A, Pace L, Di Salle F, Di Gennaro F, Salvatore M, Sodano A: Scintimammography with 99mTc-MIBI versus dynamic MRI for non-invasive characterization of breast masses. Eur J Nucl Med Mol Imaging 2001:28: 56-63.
18. Bagni B, Franceschetto A, Casolo A, De Santis M, Bagni I, Pansini F, Di Leo C: Scintimammography with 99mTc-MIBI and magnetic resonance imaging in the evaluation of breast cancer. Eur J Nucl Med Mol Imaging 2003;30:1383-1388.
19. Boné B, Wiberg MK, Szabó BK, Szakos A, Danielsson R: Comparison of 99mTc-sestamibi scintimammography and dynamic MR imaging as adjuncts to mammography in the diagnosis of breast cancer. Acta Radiologica 2003;44:28-34.
20. Paz A, Melloul M, Cytron S, Koren R, Ohana G, Michalevich D, Gal R, Wolloch Y: The value of early and double phase 99mTc-sestamibi scintimammography in the diagnosis of breast cancer. Nucl Med Commun 2000;21:341-348.
21. Arslan N, Ozturk E, Ilgan S, Narin Y, Dundar S, Tufan T, Pekcan M, Bayhan H: The comparison of dual phase Tc-99m MIBI and Tc-99m MDP scintimammography in the evaluation of breast masses: Preliminary report. Ann Nucl Med 2000;14:39-46.